TAROTARO PHARMACEUTICAL INDUSTR...

NYSE taro.com


$ 42.26 $ -0.03 (-0.07 %)    

Tuesday, 23-Apr-2024 15:52:29 EDT
QQQ $ 426.27 $ 6.25 (1.49 %)
DIA $ 385.03 $ 2.65 (0.69 %)
SPY $ 505.65 $ 5.93 (1.19 %)
TLT $ 89.02 $ 0.03 (0.03 %)
GLD $ 214.96 $ -0.53 (-0.25 %)
$ 42.23
$ 42.29
$ 42.23 x 100
$ 0.00 x 0
$ 42.22 - $ 42.29
$ 24.39 - $ 45.76
22,565
na
1.59B
$ 0.42
$ 62.38
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 krensavage-asset-management-remains-opposed-to-sun-pharmas-predatory-bid-for-taro-pharma

Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Lt...

 taro-pharmaceutical-indus-q3-2024-gaap-eps-054-beats-030-estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate ...

 taro-pharmaceutical-indus-q3-sales-15710m-beat-15491m-estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly sales of $157.10 million which beat the analyst consensus estimate of ...

 earnings-scheduled-for-january-25-2024

Companies Reporting Before The Bell • Nokia (NYSE:NOK) is projected to report quarterly earnings at $0.15 per share on revenue...

 hc-wainwright--co-downgrades-taro-pharmaceutical-indus-to-neutral-maintains-price-target-to-43

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Taro Pharmaceutical Indus (NYSE:TARO) from Buy to Neutral and ...

 taro-pharmaceutical-entered-into-definitive-merger-agreement-with-sun-pharma-sun-pharma-to-acquire-all-taros-outstanding-ordinary-shares-of-taro-for-43share

Agreed Price of US$43.00 per Share to Deliver 48% Premium to Unaffected Price on May 25, 2023

 taro-pharmaceutical-indus-q2-2023-adjeps-038-beats-018-estimate-sales-14820m-miss-16114m-estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate ...

 earnings-scheduled-for-october-26-2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on re...

 taro-pharmaceutical-indus-q1-eps-027-down-from-037-yoy-sales-15889m-up-from-15666m-yoy

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.27 per share. This is a 27.03 percent decrease over ear...

 earnings-scheduled-for-july-26-2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is estimated to report quarterly earnings at $0.87 per share on revenue o...

 why-nvidia-shares-are-trading-higher-by-over-5-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek S...

 sun-pharma-parent-taro-pharmaceutical-industries-updates-on-ransomware-incident

 As previously disclosed, on March 1, 2023, Sun Pharmaceutical Industries Ltd. (“Sun”), the parent company of Taro Pharmaceutic...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 479 stocks made new 52-week lows.

 hc-wainwright--co-maintains-buy-on-taro-pharmaceutical-indus-lowers-price-target-to-35

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and lowers the...

 taro-pharmaceutical-indus-q3-eps-019-may-not-compare-to-087-estimate-sales-13920m-miss-16312m-estimate

Taro Pharmaceutical Indus (NYSE:TARO) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimat...

 earnings-scheduled-for-january-24-2023

Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue ...

 earnings-scheduled-for-october-27-2022

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per shar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION